Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Instacart, ARS Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Published 20/09/2023, 11:23
Updated 20/09/2023, 12:40
© Reuters. Instacart, ARS Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

  • ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares dipped 46.8% to $3.51 in pre-market trading after the FDA issued a Complete Response Letter for ARS Pharma's neffy® Epinephrine nasal spray, with request for additional study.
  • Revance Therapeutics, Inc. (NASDAQ: RVNC) shares declined 5.8% to $13.01 in pre-market trading. Revance Therapeutics shares fell 17% on Tuesday after the company said it commenced a plan to exit the OPUL payments business and expects to record a restructuring charge of up to $7 million.
  • Instacart (Maplebear Inc.) (NASDAQ: CART) shares fell 4.4% to $32.21 in pre-market trading after gaining 12% on Tuesday. Instacart priced its IPO at $30 per share late Monday, which was at the top end of the expected range. Needham initiated coverage on Maplebear with a Hold rating.
  • Meta Data Limited (NYSE: AIU) shares fell 4% to $0.96 in pre-market trading after declining around 5% on Tuesday.
  • Nikola Corporation (NASDAQ: NKLA) shares declined 3.2% to $1.50 in pre-market trading. Nikola recently announced the appointment of a new chief operating officer.
  • Toyota Motor Corporation (NYSE: TM) shares fell 2.6% to $190.06 in pre-market trading after adding 3% on Tuesday.

Don’t forget to check out our premarket coverage here

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.